23andMe is a privately held personal genomics and biotechnology company based in Mountain View, California
The company is named for the 23 pairs of chromosomes in a normal human cell. Its saliva-based direct-to-consumer genetic testing business was named Invention of the Year by Time magazine in 2008.
In 2013 the US Food and Drug Administration (FDA) ordered 23andMe to discontinue marketing its personal genome service (PGS), as the company had not obtained the legally required regulatory approval. That resulted in concerns about the potential consequences of customers receiving inaccurate health results. The company continued to sell a personal genome test without health-related results in the United States until October 21, 2015, when it announced that it would be including a revised health component with FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the United Kingdom since December 2014.
More about 23andme: